Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 5/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | HEXB | P07686 | 2/20 | 0.34 |
| ▸ | HEXA | P06865 | 1/20 | 0.34 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.34 |
| ▸ | PYGB | P11216 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22659911 | 1.00 | OGA (0.37) | OGAMAPK1HEXBHEXASLC2A1 | |
| SCHEMBL14939309 | 1.00 | OGA (0.37) | OGAMAPK1HEXBHEXASLC2A1 | |
| SCHEMBL1747616 | 1.00 | OGA (0.37) | OGAMAPK1HEXBHEXASLC2A1 | |
| SCHEMBL1745769 | 0.94 | MAPK1 (0.39) | OGAMAPK1SLC2A1ADORA2AADORA2B | |
| SCHEMBL1746033 | 0.94 | MAPK1 (0.39) | OGAMAPK1SLC2A1ADORA2AADORA2B | |
| SCHEMBL13157184 | 0.80 | L3MBTL1 (0.44) | MAPK1 | |
| SCHEMBL5309010 | 0.80 | L3MBTL1 (0.44) | MAPK1 | |
| SCHEMBL14939003 | 0.80 | L3MBTL1 (0.44) | MAPK1 | |
| SCHEMBL1746441 | 0.80 | L3MBTL1 (0.44) | MAPK1 | |
| SCHEMBL17651845 | 0.80 | L3MBTL1 (0.44) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020232194-A1 | METHODS FOR GLYCOSYLATION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2020-11-19 | — | — | WO | disclosed |
| EP-2563337-B1 | CARRIER AND TARGETING SYSTEM COMPRISING A SIOSOMAL COMPOSITION FOR INTRACELLULAR DELIVERY AND TARGETING OF ACTIVE SUBSTANCE | SALAMA ZOSER B (DE) | 2017-07-26 | — | — | EP | disclosed |
| EP-2384743-A1 | Siosomal formulation for intracellular delivery and targeting of therapeutic agents | Salama, Zoser B. (DE) | 2011-11-09 | — | — | EP | disclosed |